82 FR 15271 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 82, Issue 57 (March 27, 2017)
Federal Motor Carrier Safety Administration
Federal Register Volume 82, Issue 57 (March 27, 2017)
| Page Range | 15271-15277 | |
| FR Document | 2017-05966 |
[Federal Register Volume 82, Number 57 (Monday, March 27, 2017)] [Notices] [Pages 15271-15277] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-05966] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2017-0030] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 40 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before April 26, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2017-0030 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 40 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b) (3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Felix M. Alicea Mr. Alicea, 58, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Alicea understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Alicea meets the [[Page 15272]] requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Ryan T. Anderson Mr. Anderson, 21, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Anderson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Anderson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Montana. Vladimir Azbel Mr. Azbel, 61, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Azbel understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Azbel meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class B CDL from New York. Darren E. Barrett Mr. Barrett, 47, has had ITDM since 2007. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Barrett understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Barrett meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Arizona. Douglas D. Bartley Mr. Bartley, 71, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bartley understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bartley meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Carolina. Haydee G. Bast Ms. Bast, 54, has had ITDM since 2015. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Bast understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Bast meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class C CDL from New York. Robert D. Bravo Mr. Bravo, 34, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bravo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bravo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from California. John E. Carter Mr. Carter, 51, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carter understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carter meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Alabama. Christopher A. Cleaves Mr. Cleaves, 49, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cleaves understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cleaves meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Maine. Jacob M. Cox Mr. Cox, 22, has had ITDM since 2008. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in [[Page 15273]] the last 5 years. His endocrinologist certifies that Mr. Cox understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cox meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New York. Larry S. Crosby Mr. Crosby, 44, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Crosby understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Crosby meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Dean G. Franck Mr. Franck, 42, has had ITDM since 1996. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Franck understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Franck meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Colorado. Irving Gandy 3rd Mr. Gandy, 67, has had ITDM since 1996. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Gandy understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Gandy meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New Jersey. Bryan D. Giddings Mr. Giddings, 50, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Giddings understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Giddings meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Indiana. Sidney Greenlee Mr. Greenlee, 27, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Greenlee understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Greenlee meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Caleb D. Jahn Mr. Jahn, 33, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Jahn understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Jahn meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Colorado. Jason T. Langshaw Mr. Langshaw, 24, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Langshaw understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Langshaw meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Rhode Island. John L. Lensch Mr. Lensch, 64, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lensch understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lensch meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Jaxon S. Lind Mr. Lind, 21, has had ITDM since 2004. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or [[Page 15274]] resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lind understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lind meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. Jesse E. Long Mr. Long, 29, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Long understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Long meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Connecticut. Gregory B. Lowry Mr. Lowry, 52, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lowry understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lowry meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Utah. Paul J. Marsh Mr. Marsh, 62, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Marsh understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marsh meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Richard D. Marty Mr. Marty, 34, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Marty understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Marty meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Washington. Scott A. Meade Mr. Meade, 46, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Meade understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Meade meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Pedro Mejia Mr. Mejia, 37, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Mejia understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mejia meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. Maynard D. Moore Mr. Moore, 68, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Moore understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Moore meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Missouri. Bret D. Noffke Mr. Noffke, 44, has had ITDM since 1982. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Noffke understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Noffke meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Wisconsin. [[Page 15275]] Dennis K. Rottenbucher Mr. Rottenbucher, 57, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Rottenbucher understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Rottenbucher meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Dakota. Joseph J. Schwartz Mr. Schwartz, 66, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Schwartz understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Schwartz meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Benjamin N. Smith Mr. Smith, 28, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Connecticut. Matthew Spahr Mr. Spahr, 30, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Spahr understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Spahr meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Aaron M. Stoltzfus Mr. Stoltzfus, 27, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Stoltzfus understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Stoltzfus meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from South Carolina. Daniel Suarez Mr. Suarez, 57, has had ITDM since 2009. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Suarez understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Suarez meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Tyler B. Terrill Mr. Terrill, 31, has had ITDM since 1998. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Terrill understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Terrill meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Jason M. Thomas Mr. Thomas, 36, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Thomas understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Thomas meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kentucky. Steven L. Tiefenthaler Mr. Tiefenthaler, 56, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies [[Page 15276]] that Mr. Tiefenthaler understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tiefenthaler meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Iowa. Joseph D. Wallace Mr. Wallace, 51, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Wallace understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wallace meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. David L. White Mr. White, 58, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. White understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. White meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Arkansas. Paul B. Woodward Mr. Woodward, 58, has had ITDM since 2009. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Woodward understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Woodward meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Miguel L. Xilotl Mr. Xilotl, 34, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Xilotl understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Xilotl meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Minnesota. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0030 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final [[Page 15277]] determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0030 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: March 20, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017-05966 Filed 3-24-17; 8:45 am] BILLING CODE 4910-EX-P
![Federal Register / Vol. 82, No. 57 / Monday, March 27, 2017 / Notices 15271
for drivers of LCVs [Intermodal Surface DEPARTMENT OF TRANSPORTATION acknowledgment that we received your
Transportation Efficiency Act of 1991 comments, please include a self-
(ISTEA), Pub. L. 102–240, 105 Stat. Federal Motor Carrier Safety addressed, stamped envelope or
1914, 2152, 49 USCA § 2302 NOTE]. Administration postcard or print the acknowledgement
The Secretary of Transportation [Docket No. FMCSA–2017–0030] page that appears after submitting
delegated responsibility for establishing comments on-line.
these requirements to FMCSA (49 CFR Qualification of Drivers; Exemption Privacy Act: In accordance with 5
1.87), and on March 30, 2004, after Applications; Diabetes Mellitus U.S.C. 553(c), DOT solicits comments
appropriate notice and solicitation of from the public to better inform its
public comment, FMCSA established AGENCY: Federal Motor Carrier Safety rulemaking process. DOT posts these
the current training requirements for Administration (FMCSA), DOT. comments, without edit, including any
operators of LCVs (69 FR 16722). The ACTION: Notice of applications for personal information the commenter
regulations bar motor carriers from exemptions; request for comments. provides, to www.regulations.gov, as
permitting their drivers to operate an described in the system of records
LCV if they have not been properly SUMMARY: FMCSA announces receipt of notice (DOT/ALL–14 FDMS), which can
trained in accordance with the applications from 40 individuals for be reviewed at www.dot.gov/privacy.
requirements of 49 CFR 380.113. Drivers exemption from the prohibition against FOR FURTHER INFORMATION CONTACT: Ms.
receive an LCV Driver-Training persons with insulin-treated diabetes Christine A. Hydock, Chief, Medical
Certificate upon successful completion mellitus (ITDM) operating commercial Programs Division, (202) 366–4001,
of these training requirements. Motor motor vehicles (CMVs) in interstate fmcsamedical@dot.gov, FMCSA,
carriers employing an LCV driver must commerce. If granted, the exemptions Department of Transportation, 1200
verify the driver’s qualifications to would enable these individuals with New Jersey Avenue SE., Room W64–
operate an LCV, and must maintain a ITDM to operate CMVs in interstate 113, Washington, DC 20590–0001.
copy of the LCV Driver-Training commerce. Office hours are 8:30 a.m. to 5 p.m., e.t.,
Certificate and present it to authorized DATES: Comments must be received on Monday through Friday, except Federal
Federal, State or local officials upon or before April 26, 2017. holidays.
request. ADDRESSES: You may submit comments SUPPLEMENTARY INFORMATION:
The LCV regulations have not bearing the Federal Docket Management I. Background
changed, but the Agency is increasing System (FDMS) Docket No. FMCSA–
its estimate of the IC burden to 5,565 2017–0030 using any of the following Under 49 U.S.C. 31136(e) and 31315,
hours because the population of CMV methods: FMCSA may grant an exemption from
drivers receiving LCV training and the • Federal eRulemaking Portal: Go to the Federal Motor Carrier Safety
number of drivers being certified to http://www.regulations.gov. Follow the Regulations for a 2-year period if it finds
operate LCVs have both increased based on-line instructions for submitting ‘‘such exemption would likely achieve a
upon U.S. Department of Labor data. comments. level of safety that is equivalent to or
• Mail: Docket Management Facility; greater than the level that would be
The Agency received one comment to achieved absent such exemption.’’ The
the 60-day Federal Register notice of U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building statute also allows the Agency to renew
October 14, 2016. The comment did not exemptions at the end of the 2-year
address the paperwork burden; instead, Ground Floor, Room W12–140,
Washington, DC 20590–0001. period. The 40 individuals listed in this
it lamented the existence of the notice have recently requested such an
requirement that operators of LCVs • Hand Delivery: West Building
Ground Floor, Room W12–140, 1200 exemption from the diabetes prohibition
receive specialized training. As in 49 CFR 391.41(b) (3), which applies
explained above, the Motor Carrier Act New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., e.t., to drivers of CMVs in interstate
of 1991 directed the Secretary of commerce. Accordingly, the Agency
Transportation to establish these LCV Monday through Friday, except Federal
Holidays. will evaluate the qualifications of each
training requirements. applicant to determine whether granting
• Fax: 1–202–493–2251.
Public Comments Invited Instructions: Each submission must the exemption will achieve the required
include the Agency name and the level of safety mandated by statute.
FMCSA requests that you comment
docket numbers for this notice. Note II. Qualifications of Applicants
on any aspect of this information
that all comments received will be
collection, including: (1) Whether the Felix M. Alicea
posted without change to http://
proposed collection is necessary for
www.regulations.gov, including any Mr. Alicea, 58, has had ITDM since
FMCSA to perform its functions, (2) the
personal information provided. Please 2014. His endocrinologist examined him
accuracy of the estimated burden, (3)
see the Privacy Act heading below for in 2017 and certified that he has had no
ways for the FMCSA to enhance the
further information. severe hypoglycemic reactions resulting
quality, usefulness, and clarity of the
Docket: For access to the docket to in loss of consciousness, requiring the
collected information, and (4) ways that
read background documents or assistance of another person, or
the burden could be minimized without
comments, go to http:// resulting in impaired cognitive function
reducing the quality of the collected
www.regulations.gov at any time or that occurred without warning in the
asabaliauskas on DSK3SPTVN1PROD with NOTICES
information.
Room W12–140 on the ground level of past 12 months and no recurrent (2 or
Issued under the authority delegated in 49 the West Building, 1200 New Jersey more) severe hypoglycemic episodes in
CFR 1.87 on: March 20, 2017. Avenue SE., Washington, DC, between 9 the last 5 years. His endocrinologist
G. Kelly Regal, a.m. and 5 p.m., e.t., Monday through certifies that Mr. Alicea understands
Associate Administrator for Office of Friday, except Federal holidays. The diabetes management and monitoring,
Research and Information Technology. Federal Docket Management System has stable control of his diabetes using
[FR Doc. 2017–05975 Filed 3–24–17; 8:45 am] (FDMS) is available 24 hours each day, insulin, and is able to drive a CMV
BILLING CODE 4910–EX–P 365 days each year. If you want safely. Mr. Alicea meets the
VerDate Sep<11>2014 18:02 Mar 24, 2017 Jkt 241001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1](https://thefederalregister.org/doc/82_FR_15328/page/1.svg)
![Federal Register / Vol. 82, No. 57 / Monday, March 27, 2017 / Notices 15277
determination at any time after the close Programs Division, 202–366–4001, www.regulations.gov at any time or
of the comment period. fmcsamedical@dot.gov, FMCSA, Room W12–140 on the ground level of
Department of Transportation, 1200 the West Building, 1200 New Jersey
V. Viewing Comments and Documents
New Jersey Avenue SE., Room W64– Avenue SE., Washington, DC, between 9
To view comments, as well as any 224, Washington, DC 20590–0001. a.m. and 5 p.m., e.t., Monday through
documents mentioned in this preamble, Office hours are from 8:30 a.m. to 5 Friday, except Federal holidays. The
go to http://www.regulations.gov and in p.m., e.t., Monday through Friday, FDMS is available 24 hours each day,
the search box insert the docket number except Federal holidays. If you have 365 days each year. If you want
FMCSA–2017–0030 and click ‘‘Search.’’ questions regarding viewing or acknowledgment that we received your
Next, click ‘‘Open Docket Folder’’ and submitting material to the docket, comments, please include a self-
you will find all documents and contact Docket Services, telephone (202) addressed, stamped envelope or
comments related to this notice. 366–9826. postcard or print the acknowledgement
Issued on: March 20, 2017. ADDRESSES: You may submit comments page that appears after submitting
Larry W. Minor, bearing the Federal Docket Management comments online.
Associate Administrator for Policy. System (FDMS) Docket No. FMCSA– Privacy Act: In accordance with 5
[FR Doc. 2017–05966 Filed 3–24–17; 8:45 am] 1998–4334; FMCSA–2000–7006; U.S.C. 553(c), DOT solicits comments
BILLING CODE 4910–EX–P FMCSA–2000–7918; FMCSA–2002– from the public to better inform its
12844; FMCSA–2002–13411; FMCSA– rulemaking process. DOT posts these
2003–14223; FMCSA–2004–18885; comments, without edit, including any
DEPARTMENT OF TRANSPORTATION FMCSA–2005–20027; FMCSA–2006– personal information the commenter
25246; FMCSA–2006–26066; FMCSA– provides, to http://www.regulations.gov,
Federal Motor Carrier Safety 2008–0231; FMCSA–2008–0292; as described in the system of records
Administration FMCSA–2008–0340; FMCSA–2008– notice (DOT/ALL–14 FDMS), which can
[Docket No. FMCSA–1998–4334; FMCSA– 0398; FMCSA–2010–0161; FMCSA– be reviewed at http://www.dot.gov/
2000–7006; FMCSA–2000–7918; FMCSA– 2010–0187; FMCSA–2010–0287; privacy.
2002–12844; FMCSA–2002–13411; FMCSA– FMCSA–2010–0354; FMCSA–2010– I. Background
2003–14223; FMCSA–2004–18885; FMCSA– 0372; FMCSA–2010–0385; FMCSA–
2005–20027; FMCSA–2006–25246; FMCSA– 2010–0413; FMCSA–2011–0010; Under 49 U.S.C. 31136(e) and 31315,
2006–26066; FMCSA–2008–0231; FMCSA–
FMCSA–2012–0106; FMCSA–2012– FMCSA may grant an exemption for two
2008–0292; FMCSA–2008–0340; FMCSA– years if it finds ‘‘such exemption would
2008–0398; FMCSA–2010–0161; FMCSA– 0161; FMCSA–2012–0215; FMCSA–
2012–0280; FMCSA–2012–0337; likely achieve a level of safety that is
2010–0187; FMCSA–2010–0287; FMCSA– equivalent to or greater than the level
2010–0354; FMCSA–2010–0372; FMCSA– FMCSA–2012–0338; FMCSA–2013–
2010–0385; FMCSA–2010–0413; FMCSA– 0021; FMCSA–2013–0022; FMCSA– that would be achieved absent such
2011–0010; FMCSA–2012–0106; FMCSA– 2013–0023; FMCSA–2014–0003; exemption.’’ The statute also allows the
2012–0161; FMCSA–2012–0215; FMCSA– FMCSA–2014–0006; FMCSA–2014– Agency to renew exemptions at the end
2012–0280; FMCSA–2012–0337; FMCSA– 0011; FMCSA–2014–0296; FMCSA– of the two-year period.
2012–0338; FMCSA–2013–0021; FMCSA– The physical qualification standard
2013–0022; FMCSA–2013–0023; FMCSA– 2014–0298; FMCSA–2014–0300;
for drivers regarding vision found in 49
2014–0003; FMCSA–2014–0006; FMCSA– FMCSA–2014–0301; FMCSA–2014–
CFR 391.41(b)(10) states that a person is
2014–0011; FMCSA–2014–0296; FMCSA– 0302; FMCSA–2014–0304 using any of
physically qualified to driver a CMV if
2014–0298; FMCSA–2014–0300; FMCSA– the following methods:
that person:
2014–0301; FMCSA–2014–0302; FMCSA– • Federal eRulemaking Portal: Go to
2014–0304] http://www.regulations.gov. Follow the Has distant visual acuity of at least 20/40
online instructions for submitting (Snellen) in each eye without corrective
Qualification of Drivers; Exemption lenses or visual acuity separately corrected to
comments.
Applications; Vision 20/40 (Snellen) or better with corrective
• Mail: Docket Management Facility; lenses, distant binocular acuity of a least 20/
AGENCY: Federal Motor Carrier Safety U.S. Department of Transportation, 1200 40 (Snellen) in both eyes with or without
Administration (FMCSA), DOT. New Jersey Avenue SE., West Building corrective lenses, field of vision of at least
ACTION: Notice of renewal of Ground Floor, Room W12–140, 70° in the horizontal meridian in each eye,
exemptions; request for comments. Washington, DC 20590–0001. and the ability to recognize the colors of
• Hand Delivery: West Building traffic signals and devices showing red,
SUMMARY: FMCSA announces its Ground Floor, Room W12–140, 1200 green, and amber.
decision to renew exemptions for 126 New Jersey Avenue SE., Washington, The 126 individuals listed in this
individuals from the vision requirement DC, between 9 a.m. and 5 p.m., e.t., notice have requested renewal of their
in the Federal Motor Carrier Safety Monday through Friday, except Federal exemptions from the vision standard in
Regulations (FMCSRs) for interstate Holidays. 49 CFR 391.41(b)(10), in accordance
commercial motor vehicle (CMV) • Fax: 1–202–493–2251. with FMCSA procedures. Accordingly,
drivers. The exemptions enable these Instructions: Each submission must FMCSA has evaluated these
individuals to continue to operate CMVs include the Agency name and the applications for renewal on their merits
in interstate commerce without meeting docket number(s) for this notice. Note and decided to extend each exemption
the vision requirement in one eye. that all comments received will be
asabaliauskas on DSK3SPTVN1PROD with NOTICES
for a renewable two-year period.
DATES: Each group of renewed posted without change to http://
exemptions was effective on the dates www.regulations.gov, including any II. Request for Comments
stated in the discussions below and will personal information provided. Please Interested parties or organizations
expire on the dates stated in the see the Privacy Act heading below for possessing information that would
discussions below. Comments must be further information. otherwise show that any, or all, of these
received on or before April 26, 2017. Docket: For access to the docket to drivers are not currently achieving the
FOR FURTHER INFORMATION CONTACT: Ms. read background documents or statutory level of safety should
Christine A. Hydock, Chief, Medical comments, go to http:// immediately notify FMCSA. The
VerDate Sep<11>2014 18:02 Mar 24, 2017 Jkt 241001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 E:\FR\FM\27MRN1.SGM 27MRN1](https://thefederalregister.org/doc/82_FR_15328/page/7.svg)
Document Created: 2017-03-25 00:21:34
Document Modified: 2017-03-25 00:21:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before April 26, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 82 FR 15271 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR